From Molecule to Mock Human: Why Programmable Virtual Humans Could Rewrite Drug Discovery
TL;DR for operators A recent paper proposes programmable virtual humans (PVHs): dynamic, multiscale computational models intended to simulate how a new molecule moves through, interacts with, and perturbs human biology from molecular binding to clinical phenotype.1 The operational point is not that pharma now has a magic patient simulator. It does not. The paper is a perspective and roadmap, not a benchmarked product release with clinical validation, regulatory acceptance, and a procurement form attached. Shame, really. ...